| Record ID | marc_records_scriblio_net/part18.dat:76655:1153 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part18.dat:76655:1153?format=raw |
LEADER: 01153pam 2200313 a 4500
001 85011051
003 DLC
005 19860113000000.0
008 850429s1985 flua b 10000 eng d
010 $a 85011051
020 $a0126431604
040 $aDNLM/DLC$cDLC
050 1 $aRC271.B57$bB57 1985
060 $aQZ 267 B647 1984
082 0 $a616.99/4061$219
245 00 $aBleomycin chemotherapy /$cedited by Branimir Ivan Sikic, Marcel Rozencweig, Stephen K. Carter.
260 0 $aOrlando :$bAcademic Press,$c1985.
300 $axix, 316 p. :$bill. ;$c24 cm.
500 $aBased on a symposium held in San Francisco on Sept. 14 and 15, 1984, sponsored by the Northern California Cancer Program and Bristol Laboratories.
504 $aIncludes bibliographies.
650 0 $aBleomycin$xCongresses.
650 0 $aCancer$xChemotherapy$xCongresses.
650 2 $aBleomycins$xtherapeutic use$xcongresses.
650 2 $aNeoplasms$xdrug therapy$xcongresses.
700 10 $aSikic, Branimir Ivan.
700 10 $aRozencweig, Marcel.
700 10 $aCarter, Stephen K.,$d1937-
710 20 $aNorthern California Cancer Program.
710 20 $aBristol Laboratories.